Single award · grant
Allopregnanolone as Regenerative Therapeutic for Alzheimer's: Phase 2 Clinical Trial
Award ID: R01AG063826
A single federal award, with both ends of the trail linked.
$37.2M
Total award value
Award R01AG063826 is a grant from the Department of Health and Human Services to University of Arizona, $37.2M obligated, FY2019 to FY2027, for Allopregnanolone as Regenerative Therapeutic for Alzheimer's: Phase 2 Clinical Trial. The work is performed in Arizona. Source
Award details
Award typeGrant
FAINR01AG063826
Action date2019
Period92 mo
Awarding agencyDepartment of Health and Human Services →
RecipientUniversity of Arizona →
Place of performanceArizona →
Category—
Competed?Not recordedSource
Total (exact)$37,195,028
More awards to University of Arizona
awarded 2002$486.7M
awarded 2010$137.4M
awarded 1978$82.6M
More from Department of Health and Human Services
awarded 2025$110.4B
awarded 2024$100.1B
awarded 2023$92B
awarded 2022$80.5B
awarded 2021$80.5B
Why the labels? The graph is only worth anything if the links are trusted. Facts taken straight from a federal filing are Source; figures we calculate are Computed; links we infer (corporate parents, districts, similar contractors, connections between records) are Inferred, worded carefully, never asserted as fact and never a claim that one thing caused another. Spot an error? Tell us.